The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma

被引：20
|
作者：
Giuliani, Nicola [1 ]
Chiu, Martina [2 ]
Bolzoni, Marina [1 ]
Accardi, Fabrizio [1 ]
Bianchi, Massimiliano G. [2 ]
Toscani, Denise [1 ]
Aversa, Franco [1 ]
Bussolati, Ovidio [2 ]
机构：
[1] Univ Parma, Dept Clin & Expt Med, Parma, Italy
[2] Univ Parma, Dept Biomed Biotechnol & Translat Sci, Parma, Italy
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2017年 / 21卷 / 03期
关键词：
Multiple myeloma; glutamine; metabolism; target therapy; ASCT2; CANCER; CELLS; METABOLISM; GROWTH; TRANSPORTERS; ADDICTION; STRESS; MTORC1;
D O I：
10.1080/14728222.2017.1279148
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：231 / 234
页数：4
相关论文
共 50 条
  • [21] Bruton's tyrosine kinase: potential target in human multiple myeloma
    Liu, Ying
    Dong, Ying
    Jiang, Qian-Li
    Zhang, Bo
    Hu, An-Mei
    LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 177 - 181
  • [22] Intestinal Klebsiella pneumoniae Contributes to Pneumonia by Synthesizing Glutamine in Multiple Myeloma
    Wang, Yihui
    Yang, Qin
    Zhu, Yinghong
    Jian, Xingxing
    Guo, Jiaojiao
    Zhang, Jingyu
    Kuang, Chunmei
    Feng, Xiangling
    An, Gang
    Qiu, Lugui
    Li, Guancheng
    He, Yanjuan
    Zhou, Wen
    CANCERS, 2022, 14 (17)
  • [23] Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
    Spaan, Ingrid
    Raymakers, Reinier A.
    van de Stolpe, Anja
    Peperzak, Victor
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [24] Glutamine addiction: a new therapeutic target in cancer
    Wise, David R.
    Thompson, Craig B.
    TRENDS IN BIOCHEMICAL SCIENCES, 2010, 35 (08) : 427 - 433
  • [25] A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
    Kassambara, Alboukadel
    Gourzones-Dmitriev, Claire
    Sahota, Surinder
    Reme, Thierry
    Moreaux, Jerome
    Goldschmidt, Hartmut
    Constantinou, Angelos
    Pasero, Philippe
    Hose, Dirk
    Klein, Bernard
    ONCOTARGET, 2014, 5 (09) : 2487 - 2498
  • [26] Role of Interleukin 16 in Multiple Myeloma Pathogenesis: A Potential Novel Therapeutic Target?
    Mahindra, Anuj
    Anderson, Kenneth C.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (13) : 964 - 965
  • [27] Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention
    Muranaka, Hayato
    Akinsola, Rasaq
    Billet, Sandrine
    Pandol, Stephen J.
    Hendifar, Andrew E.
    Bhowmick, Neil A.
    Gong, Jun
    CANCERS, 2024, 16 (05)
  • [28] The mTOR Signaling Pathway is an Emerging Therapeutic Target in Multiple Myeloma
    Li, Jie
    Zhu, Jingyu
    Cao, Biyin
    Mao, Xinliang
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (01) : 125 - 135
  • [29] Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
    Minami, J.
    Suzuki, R.
    Mazitschek, R.
    Gorgun, G.
    Ghosh, B.
    Cirstea, D.
    Hu, Y.
    Mimura, N.
    Ohguchi, H.
    Cottini, F.
    Jakubikova, J.
    Munshi, N. C.
    Haggarty, S. J.
    Richardson, P. G.
    Hideshima, T.
    Anderson, K. C.
    LEUKEMIA, 2014, 28 (03) : 680 - 689
  • [30] CD84: A Potential Novel Therapeutic Target in the Multiple Myeloma Microenvironment
    Gunes, Emine Gulsen
    Lewinsky, Hadas
    Viola, Domenico
    Caserta, Enrico
    Rosenzweig, Michael
    Htut, Myo
    Sanchez, James
    Buettner, Ralf
    Marcucci, Guido
    Keats, Jonathan
    Pichiorri, Flavia
    Shachar, Idit
    Rosen, Steven
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E148 - E149
12345